Faculty Member
Past and Current
Students |
Pre or Post |
Training Period Start |
Training Period End |
Prior Academic Degree |
Research Project |
Current Position or Source of Support 3 |
Degree |
Year |
Institution |
L. Jackson Roberts, M.D. |
Past Students
|
Cynthia Brame
|
Pre |
1994 |
1999 |
B.S./PhD |
|
Centre College, Vanderbilt University |
Characterization of the formation of isoketals in vivo |
N/A |
S. Baertschi
|
Pre |
1987 |
1989 |
Ph.D. |
1985 |
Vanderbilt University |
Molecular mechanisms of albumin catalyzed isomerization of prostaglandin D2 |
Res. ScientistEli Lilly Pharm. Co. |
W. Parsons
|
Pre |
1987 |
1989 |
Ph.D. |
1985 |
Vanderbilt University |
Transformation of prostaglandin D2 by human eosinophils |
Fellow, Gastroenterology, Brigham and Women's Hospital |
K. Siebert
|
Pre |
1984 |
1987 |
Ph.D. |
1985 |
Vanderbilt University |
Transformation of prostaglandin Res. Scientist
D2 to prostaglandin F2 isomers |
Program DirectorGD Searle |
T. Liston
|
Pre |
1982 |
1985 |
Ph.D. |
1985 |
Vanderbilt University |
Metabolism of prostaglandin D2 in humans |
Res. Scientist Pfizer Pharm. Co. |
Nathalie Bernoud-Hubac
|
Post |
2000 |
2002 |
PhD |
1998 |
INSA Lyon, France |
Characterization of neuroketals |
Postdoctoral Fellow, Biochemistry and Pharmacology, Natl Inst of Science and Medical Research , France |
Y. Chen
|
Post |
1997 |
1999 |
PhD |
|
Harbin Medical Univ., China/Univ. N. Dakota. |
C haracterization of cyclopentenone isoprostanes |
took position in industry |
A. Longmire
|
Post |
1992 |
1994 |
M.D. |
1971 |
Univ. of Mississippi |
Comparative evaluation of F2- isoprostane formatio to assess lipid peroxidation |
Medical OfficerFDA |
S. O'Byrne
|
Post |
1992 |
1994 |
M.D. |
1983 |
Univ. of Galway, Ireland |
Characterization of a putative anion Transporter in monocytes |
Lecturer, Senior Registrar, Human Drug Research Center, Leiden University, Netherlands |
J. Morrow
|
Post |
1988 |
1994 |
M.D. |
1983 |
Washington Univ. |
Biochemistry and pharmacology of F2-Isoprostanes |
Associate Professor, Medicine and Pharmacology, Vanderbilt University |
J. Awad
|
Post |
1990 |
1992 |
M.D. |
1985 |
Washington Univ. |
Identification of urinary metabolites of non-cyclooxgenase derived prostanoids |
Asst. Professor, Medicine, Vanderbilt University |
K. Takahashi
|
Post |
1990 |
1992 |
M.D. |
1978 |
Hokkaido Univ., Japan |
Production of lipoxygenase products in glomerular immune injury |
Clin. Res. Director Merck Sharpe & Dome, Japan |
C. Arzubiaga
|
Post |
1988 |
1989 |
M.D. |
1981 |
Univ. of Peruana Cayetano, Peru |
Activation of Mast Cells by neuropeptide Y |
Dept. of Dermatology, VA Hospital, Murfreesboro, TN |
J. Atsmon
|
Post |
1987 |
1988 |
M.D. |
1976 |
Tel-Aviv Univ. |
Role of thiol conjugate formation in the antigrowth effects of 12-prostaglandin J2 |
Ganey Zahla, Tel-Avis, Israel |
D. Wendelborn
|
Post |
1986 |
1987 |
M.D. |
1981 |
Univ. of Virginia |
Formation of isomeric prostaglandin F2 metabolites fromprostaglandin D2 |
Private Practice, Appleton, WI |
R. Dworski
|
Post |
1985 |
1987 |
M.D. |
1985 |
Copernicus Sch. of Med |
Antigen-induced release of eicosanoids into bronchoalveolar lavage fluid |
Assistant Professor, Pulmonary Medicine, Vanderbilt Univ. |
J. Turk
|
Post |
1980 |
1982 |
M.D. |
1976 |
Washington Univ. |
Leukojriene formation by human eosinophils |
Assoc. Professor, Medicine, Washington University |
Joshua Fessel
|
Pre |
2000 |
2003 |
BS. |
19992003 |
University of Evansville/Vanderbilt |
Characterization of isofurans, new products of lipid peroxidation and their modulation by oxygen tension. |
3rd Year Medical Student Vanderbilt Medical School |
Davies Sean
|
Post |
1999 |
2003 |
PhD |
1999 |
Univ of Utah Med Center |
Determination of the role of isoKetals in neurodegenerative disease. |
Research Instructor, Pharmacology, Vanderbilt, T32 GM07569-24 Clinical Pharmacology |
Current Students
|
Kyle Arneson |
Pre |
2003 |
2007 |
B.S. |
2001 |
Univ. North Dakota |
Characterization of neurofurans |
MSTP Program |
Aaron Przybysz |
Pre |
2004 |
2008 |
B.S |
2002 |
Kalamazoo College |
Identify genes that regulate oxidative stress |
Pharmacology training grant |
